P

Precision Biosensor Inc
KOSDAQ:335810

Watchlist Manager
Precision Biosensor Inc
KOSDAQ:335810
Watchlist
Price: 2 620 KRW -1.32% Market Closed
Market Cap: ₩47.1B

Precision Biosensor Inc
Investor Relations

Precision Biosensor, Inc. develops in-vitro diagnostics technology that provides advanced diagnostic solutions. The company is headquartered in Daejeon, Daejeon. The company went IPO on 2020-12-22. The firm's main products include testers and cartridges. The testers are portable immunoassay diagnostic devices for on-site diagnosis that uses colorimetric and time-resolved fluorescence to check acute heart disease, metabolism, and inflammatory diseases. The cartridges are used in gold absorption and time-resolved fluorescence analysis diagnostic equipment, and can check acute heart disease, metabolism, and inflammatory diseases. The firm sells its products in domestic and overseas markets such as Europe, China, the Middle East, and Southeast Asia.

Show more
Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
No Earnings Calls Available

Management

Hanshin Kim
Chief Executive Officer
No Bio Available
Seunghoon Lee
Chief Financial Officer
No Bio Available
Jongmyeon Park
Chief Technology Officer
No Bio Available

Contacts

Address
DAEJEON
DAEJEON
306, Techno 2-ro, Yuseong-gu
Contacts
+82428676300
precision-bio.com